Lisinopril and Hydrochlorothiazide
- Product NDC
- 50090-2565
- 11-digit product format
- 500902565
- Labeler code
- 50090
- Product ID
- 50090-2565_0cdef2de-f08e-4c51-ba5f-1be5e32d6dd8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA077912
- Marketing category
- ANDA
- Marketing start
- 2006-10-04
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 12.5; 10 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
| E7199S1YWR | LISINOPRIL | 83915-83-7 | LISINOPRIL |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-2565-0 | 50090256500 | 30 TABLET in 1 BOTTLE (50090-2565-0) | 30 tablet | 2016-10-27 | No | No | Historical |
| 50090-2565-1 | 50090256501 | 90 TABLET in 1 BOTTLE (50090-2565-1) | 90 tablet | 2016-10-28 | No | No | Historical |
| 50090-2565-2 | 50090256502 | 100 TABLET in 1 BOTTLE (50090-2565-2) | 100 tablet | 2023-03-27 | No | No | Historical |